Exposure to 60-Hz magnetic fields may increase breast cancer risk by suppressing the nocturnal production of melatonin.Breast cancer risk was not associated with exposure to residential magnetic fields, regardless of medication use.
Systematic review of RCTs involving breast cancer patients treated with ACCs, survival, parameters indicative of tumor burden, disease progression, cancer recurrence, and cancer cure. Encouraging but not fully convincing results emerged for melatonin.
Randomized clinical trials (RCTs) Alternative cancer cures (ACCs)
Forty percent of the women with breast cancer had stage 2 disease and they were an average of 1.36years post-diagnosis. Women with breast cancer had significantly higher levels of disturbance on all the psychological indices.
Dysregulations across systems in breast cancer patients.
Alonso-González C, González A, Mazarrasa O, Güezmes A, Sánchez-Mateos S, Martínez-Campa C, Cos S, Sánchez-Barceló EJ, Mediavilla MD.
Female mice were treated with CdCl(2) (2-3 mg/kg, i.p.), melatonin (10 microg/mL in drinking water), CdCl(2) + melatonin, or diluents. The effects of Cd are partially inhibited by melatonin.